AnandRathi

ERIS Lifesciences Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
1,311.65
+2.95 (+0.23%)

ERIS Lifesciences Ltd (ERIS Lifescience) fundamental analysis breaks down the key financial metrics of the small-cap Pharmaceuticals company, which carries a market capitalisation of ₹18,177 crore.

ERIS Lifesciences Ltd Overview

Market cap₹18,177 Crs
Volume947
Prev. Close₹1,308.70
Year range₹1,237.90 - ₹1,819.25
Total Value₹12,42,132.55
ISININE406M01024

ERIS Lifesciences Ltd Fundamental Analysis

ROCE(TTM)10.22%
P/E Ratio (TTM)94.50
P/B Ratio5.69
Debt to Equity0.66
ROE7.64%
EPS (TTM)14.88
Dividend Yield0.55%
Book Value230.58
Profit Margin12.53%
Operating Margin21.29%

ERIS Lifesciences Ltd Historical Performance

1 Month Return-6.31%
6 Month Return-3.50%
3 Year Return63.91%
3 Month Return-2.90%
1 Year Return-27.17%
5 Year Return80.00%

ERIS Lifesciences Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research